No products in the cart.
Semaglutide Tablets
$1.00
Rybelsus® oral semaglutide — 7mg film-coated tablets, 10 per box, produced by Novo Nordisk A/S. The first FDA- and EMA-approved oral GLP-1 receptor agonist for type 2 diabetes. Ideal for metabolic, weight loss, and endocrinology research.
Description
Semaglutide Tablets Description
Product name: Semaglutide tablets (Novo Nordisk/Rybelsus)
Packaging specifications: 7mg*10 tablets Product dosage form: tablets Packaging unit: box
Approval number: National Medicine Standard SJ20240005 Drug standard code: 86978997003475
Manufacturer: Novo Nordisk A/S, Denmark
Rybelsus® (semaglutide) 7mg oral tablet is the world’s first approved GLP-1 receptor agonist in pill form, designed to improve glycemic control and support weight management in adults with type 2 diabetes. It mimics the incretin hormone GLP-1 to enhance insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite.
This innovative formulation uses an absorption enhancer (SNAC) to deliver semaglutide systemically — a breakthrough in peptide-based oral drug design.
Semaglutide Tablets Product Specifications
| Feature | Details |
|---|---|
| Product Name | Semaglutide Tablets (Rybelsus®) |
| Strength | 7mg per film-coated tablet |
| Packaging | 10 tablets per box |
| Dosage Form | Oral tablet |
| Manufacturer | Novo Nordisk A/S |
| Approval Number | NMPA: SJ20240005 (China) |
| Product Code | 86978997003475 |
| Barcode | — |
| Origin | Denmark |
| Storage Conditions | Store 30°C, protect from moisture and light |
| Shelf Life | As labeled |
| Administration | Once daily on empty stomach with 120ml water; wait 30–60min before food |
| Intended Use | For laboratory or analytical research only |
Semaglutide Tablets Mechanism & Clinical Highlights
GLP-1RA action: Boosts insulin, suppresses glucagon, delays gastric emptying, and reduces appetite.
Approved dosing: 3mg initial, titrating to 7mg — with demonstrated HbA1c reductions of –1.0% (7mg) and –1.3% (14mg) compared to sitagliptin.
Safety profile: Common side effects include nausea, diarrhea, and mild hypoglycemia (when used with other agents).
Pharmacokinetic note: Oral bioavailability is 0.4–1%, while injectable forms have ~89%, requiring oral dose adjustments.
Why Choose Rybelsus® Semaglutide Tablets?
Global innovations: The first oral GLP-1RA with established clinical approval
Peptide delivery breakthrough: Oral SNAC-enhanced peptide absorption
Lab-ready film tablets: Precise dosage, stable, and easy to store
Supporting research: Excellent for appetite, weight, and metabolic studies
Semaglutide Injection (Ozempic® / Wegovy®)
Exenatide, Dulaglutide – GLP?1RA injectables
Metformin, Dapagliflozin – Oral antidiabetic agents
Summary
Rybelsus® Semaglutide 7mg tablets represent a pharmacological milestone — the first oral GLP-1 receptor agonist suitable for advanced metabolic, endocrinology, and appetite-control research. Produced by Novo Nordisk, with global regulatory backing and innovative peptide delivery, it’s perfect for labs exploring GLP-1PA mechanisms.
Additional information
| Weight | 1.1 kg |
|---|---|
| Dimensions | 26 × 25 × 26 cm |
2 reviews for Semaglutide Tablets
Related products
Brolucizumab Injection (Beovu) 27.6mg/0.23ml – Factory low price wholesale
Beovu (Brolucizumab Injection) is supplied in a 0.23ml single-dose vial containing 27.6mg of active ingredient. Manufactured by Alcon-Couvreur N.V. and NMPA-approved under SJ20250019. Intended for non-clinical research use only.?For wholesale prices, other specifications and uses, please consult our staff? $2.00Gliclazide Sustained-Release Tablets 30mg (Darentang) – Factory wholesale For Laboratory Research Use Only
Gliclazide Sustained-Release Tablets (30mg) are used in laboratory research involving insulin secretion, beta-cell response, and glucose regulation in Type 2 diabetes models. Manufactured by Darentang New Xin Pharmaceutical Factory. Not for human or veterinary use.?Please consult staff for price, other specifications and uses?
$2.00Empagliflozin Tablets 10mg (Koltangen) – For Research Use Only
Empagliflozin Tablets (10mg) for research use only. Used in experimental studies on SGLT2 inhibition, glucose excretion, and type 2 diabetes models. Manufactured by Sichuan Kelun Pharmaceutical Co., Ltd.?For wholesale prices, other specifications and uses, please consult our staff?
$1.00Pioglitazone Hydrochloride Tablets (Aiting) 15mg – For Laboratory Research Use Only
Pioglitazone Hydrochloride Tablets (Aiting) contain 15mg of active compound per tablet. Supplied as 14 tablets (2 blister packs). Manufactured by Beijing Taiyang Pharmaceutical under NMPA approval H20040267. Suitable for lab research in glucose metabolism and insulin signaling.?For wholesale prices, other specifications and uses, please consult our staff?
$1.20
mnsdz –
Received it, but the logistics took too long, I waited for 12 days
djinie –
Awesome, my brother